Canzon Israel Ltd (TA:CNZN) — Market Cap & Net Worth

$1.71 Million USD  · ILA638.39 Million ILA  · Rank #30203

Market Cap & Net Worth: Canzon Israel Ltd (CNZN)

Canzon Israel Ltd (TA:CNZN) has a market capitalization of $1.71 Million (ILA638.39 Million) as of September 7, 2026. Listed on the TA stock exchange, this Israel-based company holds position #30203 globally and #441 in its home market, demonstrating a -16.11% decrease in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Canzon Israel Ltd's stock price ILA155.20 by its total outstanding shares 4113310 (4.11 Million). Also see CNZN current and non-current assets for a full breakdown of the balance sheet.

Canzon Israel Ltd Market Cap History: 2015 to 2026

Canzon Israel Ltd's market capitalization history from 2015 to 2026. Data shows change from $2.81 Billion to $1.71 Million (-49.97% CAGR). Also see cash efficiency ratio of Canzon Israel Ltd for how efficiently the company converts equity into cash flow.

Canzon Israel Ltd Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Canzon Israel Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check Canzon Israel Ltd (CNZN) share price today for real-time trading data and today's change.

Latest Price to Sales (P/S) Ratio

19.83x

Canzon Israel Ltd's market cap is 19.83 times its annual revenue

Industry average: 0.63x Higher than industry average

Latest Price to Earnings (P/E) Ratio

N/A

P/E ratio not applicable due to negative or zero earnings

What These Ratios Tell Investors:

  • Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
  • Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
  • Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
  • Industry comparison provides context for whether the company is valued higher or lower than peers.
Year Market Cap (USD) Revenue (USD) Net Income (USD) P/S Ratio P/E Ratio
2015 $2.81 Billion $12.03 Million -$1.29 Million 233.33x N/A
2016 $2.09 Billion $13.29 Million $280.00K 157.28x 7463.35x
2017 $788.48 Million $4.07 Million $122.00K 193.68x 6462.92x
2019 $10.29 Million $24.00K -$55.99 Million 428.70x N/A
2020 $8.82 Million $277.00K -$12.32 Million 31.85x N/A
2021 $4.96 Million $59.00K -$3.11 Million 84.11x N/A
2022 $4.56 Million $1.19 Million -$3.80 Million 3.83x N/A
2023 $1.96 Million $99.00K -$4.74 Million 19.83x N/A

Competitor Companies of CNZN by Market Capitalization

Companies near Canzon Israel Ltd in the global market cap rankings as of September 7, 2026. Review Canzon Israel Ltd tangible net worth ratio to assess the quality of the company's equity after excluding intangible assets.

Key companies related to Canzon Israel Ltd by market ranking:

  • Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #524 globally with a market cap of $52.60 Billion USD.
  • GALDERMA GROUP AG (NYSE:GALDY): Ranked #608 globally with a market cap of $45.51 Billion USD.
  • Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #634 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
  • Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #640 globally with a market cap of $42.96 Billion USD ( CN¥293.56 Billion CNY).
Market capitalization comparison (in billions USD)
Rank Company Symbol Market Cap Price
#524 Takeda Pharmaceutical Co Ltd ADR NYSE:TAK $52.60 Billion $16.65
#608 GALDERMA GROUP AG NYSE:GALDY $45.51 Billion $39.03
#634 Takeda Pharmaceutical Company Limited F:TKDA $43.60 Billion €15.90
#640 Jiangsu Hengrui Medicine Co Ltd SHG:600276 $42.96 Billion CN¥46.02

Canzon Israel Ltd Historical Marketcap From 2015 to 2026

Between 2015 and today, Canzon Israel Ltd's market cap moved from $2.81 Billion to $ 1.71 Million, with a yearly change of -49.97%.

Year Market Cap Change (%)
2026 ILA1.71 Million +29.33%
2025 ILA1.32 Million +9.09%
2024 ILA1.21 Million -38.20%
2023 ILA1.96 Million -56.97%
2022 ILA4.56 Million -8.07%
2021 ILA4.96 Million -43.75%
2020 ILA8.82 Million -14.26%
2019 ILA10.29 Million -96.56%
2018 ILA299.40 Million -62.03%
2017 ILA788.48 Million -62.27%
2016 ILA2.09 Billion -25.54%
2015 ILA2.81 Billion --

End of Day Market Cap According to Different Sources

On Sep 7th, 2026 the market cap of Canzon Israel Ltd was reported to be:

Source Market Cap
Yahoo Finance $1.71 Million USD
MoneyControl $1.71 Million USD
MarketWatch $1.71 Million USD
marketcap.company $1.71 Million USD
Reuters $1.71 Million USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About Canzon Israel Ltd

TA:CNZN Israel Drug Manufacturers - Specialty & Generic
Market Cap
$1.71 Million
ILA638.39 Million ILA
Market Cap Rank
#30203 Global
#441 in Israel
Share Price
ILA155.20
Change (1 day)
+0.00%
52-Week Range
ILA54.00 - ILA219.00
All Time High
ILA345000.00
About

Canzon Israel Ltd focuses on investing and managing projects in the field of initiating construction for residential and commercial purposes in Portugal. The company was formerly known as User Trend Ltd and changed its name into Canzon Israel Ltd in June 2019. Canzon Israel Ltd was incorporated in 1999 and is based in Tel Aviv, Israel.